⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARTV News
Artiva Biotherapeutics, Inc. Common Stock
Form 8-K
sec.gov
ARTV
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ARTV
U.S. Hemostatic Sealants in Arterial Surgery Market Size, Share & Trends Analysis Report by Product, End Use, Application, Disease Indication, and Segment Forecasts, 2026-2033 Published; Maps U.S. TAM Trends
globenewswire.com
ARTV
BDX
TFX
Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
globenewswire.com
ARTV
Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today
globenewswire.com
ARTV
The $13 Million Company Teaching the Immune System to Hunt Cancer
prnewswire.com
NKTX
GTBP
IBRX
FATE
ARTV
Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
globenewswire.com
ARTV
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases
globenewswire.com
ARTV
Form 8-K
sec.gov
ARTV
Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development
globenewswire.com
ARTV